Zhou Y - Search Results

1

FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway.

Wang S, Liu B, Su Y, Wang N, Dong P, Xu X, Huang L, Li S, Gu J, Qiu Y, Deng J, Lin Z, Zhou Y. Wang S, et al. Among authors: zhou y. Thorac Cancer. 2024 Mar;15(8):630-641. doi: 10.1111/1759-7714.15234. Epub 2024 Feb 7. Thorac Cancer. 2024. PMID: 38323374 Free PMC article.

2

Reduced expression of Krüppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma.

Cai XD, Zhou YB, Huang LX, Zeng QL, Zhang LJ, Wang QQ, Li SL, Feng JQ, Han AJ. Cai XD, et al. Biochem Biophys Res Commun. 2012 Feb 3;418(1):67-73. doi: 10.1016/j.bbrc.2011.12.129. Epub 2012 Jan 3. Biochem Biophys Res Commun. 2012. PMID: 22240024

3

Real-time fluorescence loop mediated isothermal amplification for the detection of Acinetobacter baumannii.

Wang Q, Zhou Y, Li S, Zhuo C, Xu S, Huang L, Yang L, Liao K. Wang Q, et al. Among authors: zhou y. PLoS One. 2013 Jul 2;8(7):e66406. doi: 10.1371/journal.pone.0066406. Print 2013. PLoS One. 2013. PMID: 23843955 Free PMC article.

4

Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression.

Zeng Q, Li S, Zhou Y, Ou W, Cai X, Zhang L, Huang W, Huang L, Wang Q. Zeng Q, et al. Among authors: zhou y. Cytokine. 2014 Jan;65(1):24-32. doi: 10.1016/j.cyto.2013.09.017. Epub 2013 Oct 18. Cytokine. 2014. PMID: 24140068

5

PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.

Gu J, Ou W, Huang L, Wu J, Li S, Xu J, Feng J, Liu B, Zhou Y. Gu J, et al. Among authors: zhou y. Minerva Med. 2016 Oct;107(5):342-51. Epub 2016 Jun 22. Minerva Med. 2016. PMID: 27333149

6

Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.

Wu J, Zhou L, Huang L, Gu J, Li S, Liu B, Feng J, Zhou Y. Wu J, et al. Among authors: zhou y, zhou l. J Exp Clin Cancer Res. 2017 Jan 5;36(1):4. doi: 10.1186/s13046-016-0477-x. J Exp Clin Cancer Res. 2017. PMID: 28057025 Free PMC article.

7

TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis.

Gu J, Zhou Y, Huang L, Ou W, Wu J, Li S, Xu J, Feng J, Liu B. Gu J, et al. Among authors: zhou y. Mol Clin Oncol. 2016 Dec;5(6):705-713. doi: 10.3892/mco.2016.1057. Epub 2016 Oct 21. Mol Clin Oncol. 2016. PMID: 28101350 Free PMC article.

8

Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study.

Gu J, Zang W, Liu B, Li L, Huang L, Li S, Rao G, Yu Y, Zhou Y. Gu J, et al. Among authors: zhou y. Oncotarget. 2017 Jun 29;8(40):67810-67820. doi: 10.18632/oncotarget.18866. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978074 Free PMC article.

9

Restoration of KLF4 Inhibits Invasion and Metastases of Lung Adenocarcinoma through Suppressing MMP2.

Li S, Huang L, Gu J, Wu J, Ou W, Feng J, Liu B, Xu X, Zhou Y. Li S, et al. Among authors: zhou y. J Cancer. 2017 Sep 27;8(17):3480-3489. doi: 10.7150/jca.21241. eCollection 2017. J Cancer. 2017. PMID: 29151932 Free PMC article.

10

In vitro effects of N-acetylcysteine alone and combined with tigecycline on planktonic cells and biofilms of Acinetobacter baumannii.

Feng J, Liu B, Xu J, Wang Q, Huang L, Ou W, Gu J, Wu J, Li S, Zhuo C, Zhou Y. Feng J, et al. Among authors: zhou y. J Thorac Dis. 2018 Jan;10(1):212-218. doi: 10.21037/jtd.2017.11.130. J Thorac Dis. 2018. PMID: 29600051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,752 results

Search Page

Filters